Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pato

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
The American Journal of Psychiatry|October 1, 1996
Social phobia and stutteringA J de Carle, M T Pato
Journal of Pharmacology & Pharmacotherapeutics|February 25, 2015
Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysisSean A Sassano-Higgins, Michele T Pato
The Annals of Pharmacotherapy|January 6, 2001
Possible risperidone-induced tardive dystoniaR Narendran, C M Young, M T Pato
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1988
[The contact-glass tonometer]Y Robert, T Pato, P Raemy, et al.
Journal of Clinical Psychopharmacology|June 1, 1991
Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuationM T Pato, D L Murphy, C L DeVane
Journal of Clinical Psychopharmacology|June 1, 1990
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agentsD L Murphy, M T Pato, T A Pigott
The Journal of Clinical Psychiatry|May 25, 2002
Recent findings in the genetics of OCDMichele T Pato, Carlos N Pato, David L Pauls
Psychopharmacology Bulletin|January 1, 1990
A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patientsM T Pato, J L Hill, D L Murphy
Current Psychiatry Reports|March 29, 2001
The genetics of obsessive-compulsive disorderM T Pato, K M Schindler, C N Pato
The Journal of Clinical Psychiatry|June 1, 1993
Current issues in the pharmacologic management of obsessive compulsive disorderS A Rasmussen, J L Eisen, M T Pato
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
The American Journal of Psychiatry|October 1, 1996
Social phobia and stutteringA J de Carle, M T Pato
Journal of Pharmacology & Pharmacotherapeutics|February 25, 2015
Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysisSean A Sassano-Higgins, Michele T Pato
The Annals of Pharmacotherapy|January 6, 2001
Possible risperidone-induced tardive dystoniaR Narendran, C M Young, M T Pato
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1988
[The contact-glass tonometer]Y Robert, T Pato, P Raemy, et al.
Journal of Clinical Psychopharmacology|June 1, 1991
Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuationM T Pato, D L Murphy, C L DeVane
Journal of Clinical Psychopharmacology|June 1, 1990
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agentsD L Murphy, M T Pato, T A Pigott
The Journal of Clinical Psychiatry|May 25, 2002
Recent findings in the genetics of OCDMichele T Pato, Carlos N Pato, David L Pauls
Psychopharmacology Bulletin|January 1, 1990
A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patientsM T Pato, J L Hill, D L Murphy
Current Psychiatry Reports|March 29, 2001
The genetics of obsessive-compulsive disorderM T Pato, K M Schindler, C N Pato
The Journal of Clinical Psychiatry|June 1, 1993
Current issues in the pharmacologic management of obsessive compulsive disorderS A Rasmussen, J L Eisen, M T Pato
Pageof 15